Home / Resource Library / Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

Results of a study examining ibrutinib for first line treatment of mantle cell lymphoma.